Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
about
Renal dopaminergic defect in C57Bl/6J miceNew Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects.Autoimmunity: an underlying factor in the pathogenesis of hypertension.Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosusN-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosusSoluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndromeThe pathophysiology of hypertension in systemic lupus erythematosus.Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosusHypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.Understanding mechanisms of hypertension in systemic lupus erythematosus.Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune DiseaseRole of the Immune System in Hypertension.Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
P2860
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
P2860
Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Differences in the occurrence ...... XSB mice with lupus nephritis.
@ast
Differences in the occurrence ...... XSB mice with lupus nephritis.
@en
type
label
Differences in the occurrence ...... XSB mice with lupus nephritis.
@ast
Differences in the occurrence ...... XSB mice with lupus nephritis.
@en
prefLabel
Differences in the occurrence ...... XSB mice with lupus nephritis.
@ast
Differences in the occurrence ...... XSB mice with lupus nephritis.
@en
P2093
P2860
P1476
Differences in the occurrence ...... BXSB mice with lupus nephritis
@en
P2093
D A Lawrence
R L Dilwith
U H Rudofsky
V E Kelley
P2860
P304
P407
P577
1984-07-01T00:00:00Z